The studies discussed above documented that IL-9-producing cells were associated with the response to anti-PD-1 treatment in cancer patients and suggested that IL-9 could be involved in the anti-tumor immune response elicited by this immunotherapy. This evidence concerns the gene IL9 and neoplasm.